Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
TrivarX Limited ( (AU:TRI) ) just unveiled an update.
TrivarX Limited announced the resignation of John Mathias as a non-executive director, effective December 31, 2025, as he plans to reduce his workload in preparation for retirement. His departure marks a significant change for the company, as he played a crucial role in promoting TrivarX’s technology to a broader market since joining the board in October 2024. The company continues to focus on its strategy to unlock value for shareholders.
More about TrivarX Limited
TrivarX Limited is a mental health technology company that focuses on pioneering the use of objective measures to aid in the early detection and screening of mental health conditions. The company is based in Australia with offices in Perth and Minneapolis, and it is listed on the Australian Securities Exchange and the OTCQB Venture Market.
YTD Price Performance: 31.25%
Average Trading Volume: 3,238,306
Technical Sentiment Signal: Sell
Current Market Cap: A$15.04M
For detailed information about TRI stock, go to TipRanks’ Stock Analysis page.